4-[6-Hydrazinyl-4-(trifluoromethyl)pyridin-2-yl]morpholine, 95.0%, 1g

6-G1 2AB (500pmol/vial)1vial

tert-Butyl 5-bromo-3-methyl-1H-indazole-1-carboxylate, 95.0%, 1g

4-Bromo-5-fluoro-2-nitrobenzaldehyde, 97%, 25g

2-amino-N,N-dimethylethanesulfonamide hydrochloride, 95.0%, 10g

1-(Oxetan-3-yl)-1h-pyrazole-4-carboxylic acid, 98%, 500mg

Ethyl 3,5-dibromo-4-hydroxybenzoate, 95+%, 250g

1-(Piperidin-1-yl)hexadecan-1-one, 98%, 250mg

(S)-3-(1-Hydroxyethyl)pyridine, 95.0%, 25g

2-Hydroxy-4-methyl-3-nitropyridine>98.0%(GC)(T)1g

5,6-dihydro-4H-cyclopenta[c]isothiazol-3-amine hydrochloride hydrate, 95.0%, 1g

Sodium 2-chloro-1-hydroxyethane-1-sulfonate, 98%, 5g

(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-ylmethyl p-toluenesulfonate, 95.0%, 1g